参考文献/References:
[1] 陈卫衡.股骨头坏死的诊治误区与对策[J].中医正骨,2013,25(3):3-5.
[2] 徐西林,张晓峰,段洪超,等.活骨注射液髋关节腔注射对兔VEGF mRNA表达影响的研究[J].中医药信息,2011,28(5):64-66.
[3] 沈霖,林燕萍,王拥军.骨伤科实验研究[M].北京:北京科学技术出版社,2005:434.
[4] 凌峰,王燕,熊龙,等.股骨头坏死病因发病机制的研究进展[J].实用临床医学,2011,12(11):132-134.
[5] Kerachian MA,Harvey EJ,Cournoyer D,et al.Avascular necrosis of the femoral head:vascular hypotheses[J].Endothelium,2006,13(4):237-244.
[6] 刘春辉,赵德伟,李志刚,等.液氮冷冻犬股骨头坏死过程中细胞因子和组织学的动态变化[J].中国骨与关节外科,2011,4(2):135-140.
[7] 于潼.硬化带在股骨头坏死塌陷作用中的研究进展[J].医学综述,2015,21(1):84-86.
[8] 周正新,孙志涛,丁锷.骨蚀宁胶囊对激素性股骨头坏死患者凝血机制的影响[J].中医正骨,2013,25(3):31-34.
[9] 蔡源源,李光早.血管内皮生长因子的调控及其作用研究进展[J].组织工程与重建外科杂志,2011,7(1):51-54.
[10] Feng L,Wu H,E L,et al.Effects of vascular endothelial growth factor 165 on bone tissue engineering[J].PLoS One,2013,8(12):e82945.
[11] Turner N,Grose R.Fibroblast growth factor signalling:from development to cancer[J].Nat Rev Cancer,2010,10(2):116-129.
[12] Pugh CW,Ratcliffe PJ.Regulation of angiogenesis by hypoxia:role of the HIF system[J].Nat Med,2003,9(6):677-684.
[13] Ishibashi H,Shiratuchi T,Nakagawa K,et al.Hypoxia-induced angiogenesis of cultured human salivary gland carcinoma cells enhances vascular endothelial growth factor production and basic fibroblast growth factor release[J].Oral Oncol,2001,37(1):77-83.
[14] Ziemer LS,Koch CJ,Maity A,et al.Hypoxia and VEGF mRNA expression in human tumors[J].Neoplasia,2001,3(6):500-508.
[15] 崔永锋,王利明,肖鲁伟,等.股骨头坏死修复过程中断的原因分析[J].中华中医药杂志,2009,24(11):1473-1476.
[16] 颜冰,王和鸣.活血补肾汤对兔激素性股骨头坏死VEGF的影响[J].中国中医骨伤科杂志,2010,18(5):1-4.
相似文献/References:
[1]陈雷雷,张颖.何伟教授采用中医药疗法治疗股骨头坏死的经验[J].中医正骨,2015,27(10):74.
[2]鲍荣华,王国平,夏晓斌,等.钽棒植入治疗非创伤性股骨头坏死的疗效观察[J].中医正骨,2015,27(02):28.
[3]张兵,马凰富,刘波,等.非创伤性股骨头坏死的舌象定量研究[J].中医正骨,2015,27(04):8.
ZHANG Bing,MA Huangfu,LIU Bo,et al.Quantitative study on tongue manifestation of patients with nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):8.
[4]李刚,程春生.股骨头坏死血瘀证症状与平乐郭氏正骨方药药物组成
最大频繁关联模式挖掘[J].中医正骨,2015,27(04):21.
LI Gang,CHENG Chunsheng.Maximal frequent association pattern mining for studying the relationship between BLOOD STASIS syndrome in patients with osteonecrosis of femoral head and drug components of Pingle Guo's orthopedics prescription[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):21.
[5]李文龙,梅沉成,杜贵强,等.微创减压植骨多孔钽棒植入治疗
ARCOⅡ期非创伤性缺血性股骨头坏死[J].中医正骨,2016,28(02):43.
[6]张磊,金红婷,童培建.骨健口服液早期干预非创伤性股骨头坏死的临床研究[J].中医正骨,2016,28(03):14.
ZHANG Lei,JIN Hongting,TONG Peijian.Clinical study on Gujian Koufuye(骨健口服液)for early intervention of nontraumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):14.
[7]鲍荣华,王国平,夏晓斌,等.直接前入路微创全髋关节置换术治疗晚期股骨头坏死[J].中医正骨,2016,28(03):61.
[8]张超,姚晨,沈计荣.微创髓芯减压打压支撑植骨术结合补肾活血汤口服治疗ARCOⅡ、Ⅲ期股骨头坏死的近期疗效观察[J].中医正骨,2016,28(03):20.
ZHANG Chao,YAO Chen,SHEN Jirong.[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):20.
[9]唐立明,庞智晖,樊粤光,等.“辨稳论治”微观辨证理念指导下的股骨头坏死围塌陷期分型及其临床应用价值[J].中医正骨,2016,28(05):63.
[10]汪倩倩,刘春芳,姜宜妮,等.补肾方对激素性股骨头坏死大鼠股骨头血管形态和血液状态的影响[J].中医正骨,2016,28(06):1.
WANG Qianqian,LIU Chunfang,JIANG Yini,et al.Effect of Bushen Fang(补肾方)on blood vessel morphous of femoral head and blood state in rats with steroid-induced necrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):1.
[11]周勇,任菲菲,丰凡翔,等.血管内皮生长因子和骨形态发生蛋白2
在非创伤性股骨头坏死不同区域的表达[J].中医正骨,2015,27(08):7.
ZHOU Yong,REN Feifei,FENG Fanxiang,et al.Expressions of vascular endothelial growth factor and bone morphogenetic protein 2 in different zones of femoral head with non-traumatic osteonecrosis[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2015,27(08):7.
[12]周勇,徐祖健,柴天朋,等.非创伤性股骨头坏死骨髓水肿与磁共振分期的关系及骨髓水肿发生机制的初步研究[J].中医正骨,2016,28(08):8.
ZHOU Yong,XU Zujian,CHAI Tianpeng,et al.A pilot study on relationship between bone marrow edema and magnetic resonance staging and pathogenesy of bone marrow edema in patients with non-traumatic osteonecrosis of femoral head[J].The Journal of Traditional Chinese Orthopedics and Traumatology,2016,28(08):8.